Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERODUO-2: AERO-007 in COPD
NCT07896252Phase 2Recruiting
- Sponsor
- AeroRx Therapeutics
- Start
- Oct 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of AERO-007 in chronic obstructive pulmonary disease (COPD), sponsored by AeroRx Therapeutics. Started Oct 2026; status: recruiting.
02
Drugs
AERO-007
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07896252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07896252.